The Patent Finder

GC Biopharma Corp.

Also on record
Records under this name other than the patents GC Biopharma Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 8 of 8 · Back to GC Biopharma Corp.

PatentTitleStatus Expires Confidence
US 11,203,749Factor VII Polypeptides That Are Modified and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,160,961Factor VII Polypeptides That Are Modified and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,476,037Factor VII polypeptides that are modified and uses thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,519,103Factor VII Polypeptides That Are Modified and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,266,724Modified Factor VII Polypeptides for Subcutaneous Administration and On-Demand Treatment
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,778,870Modified Factor IX Polypeptides and Uses Thereof
Lapsed on the fee record
Ended Jul 15, 2026 · High confidence
Lapsed on the fee recordEnded Jul 15, 2026High confidence
US 10,982,203Modified Factor IX Polypeptides and Uses Thereof
Lapsed on the fee record
Ended Apr 20, 2025 · High confidence
Lapsed on the fee recordEnded Apr 20, 2025High confidence
US 8,383,388Modified Coagulation Factor IX Polypeptides and Use Thereof for Treatment
Lapsed on the fee record
Ended Feb 26, 2025 · High confidence
Lapsed on the fee recordEnded Feb 26, 2025High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited